<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04629586</url>
  </required_header>
  <id_info>
    <org_study_id>1822333</org_study_id>
    <nct_id>NCT04629586</nct_id>
  </id_info>
  <brief_title>The T1D Exchange Registry</brief_title>
  <acronym>T1D Registry</acronym>
  <official_title>The T1D Exchange Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>T1D Exchange, United States</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>T1D Exchange, United States</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The T1D Exchange Registry is a research study, conducted over time, for individuals with type&#xD;
      1 diabetes and their supporters. Participants volunteer to provide their data for research&#xD;
      (for example, by answering questions in annual surveys). Once enrolled, Registry participants&#xD;
      have the opportunity to sign up for other studies on various topics related to type 1&#xD;
      diabetes.&#xD;
&#xD;
      To participate, you will be asked to:&#xD;
&#xD;
        -  Read and sign an online informed consent form&#xD;
&#xD;
        -  Take a survey describing specific demographic and type 1 diabetes management information&#xD;
&#xD;
        -  Update your information annually&#xD;
&#xD;
        -  Periodically opt in for additional research opportunities (if you choose), i.e. taking&#xD;
           new surveys or uploading health device data&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>Gather longitudinal data from individuals living with type 1 diabetes.</measure>
    <time_frame>10 years</time_frame>
    <description>Gather longitudinal data on disease, health status, and patient-reported outcomes of individuals living with type 1 diabetes. This will be achieved by presenting participants with an annual questionnaires, tracking any changes in their responses over time.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50000</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetes</condition>
  <condition>Type 1 Diabetes</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Individuals diagnosed with type 1 diabetes</arm_group_label>
    <description>T1D Exchange Registry is currently looking for participants:&#xD;
Of all ages, genders, races, and ethnic groups&#xD;
Living in the United States&#xD;
Diagnosed with type 1 diabetes&#xD;
Currently taking insulin or have had a pancreatic or islet cell transplant</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Observational research study</description>
    <arm_group_label>Individuals diagnosed with type 1 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individual diagnosed with type 1 diabetes who can access online Registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of type 1 diabetes.&#xD;
&#xD;
          -  Individuals younger than 18 years of age must have parent/guardian consent.&#xD;
&#xD;
          -  Must be able to read and understand English.&#xD;
&#xD;
          -  Currently living in the United States&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Does not use insulin and has not had a pancreatic or islet cell transplant.&#xD;
&#xD;
          -  Cannot fully read and understand English.&#xD;
&#xD;
          -  Does not currently live in the United States.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carolina Leon</last_name>
    <phone>(617) 892-0429</phone>
    <email>cleon@t1dexchange.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelsie LaFerriere</last_name>
    <phone>(617) 892-9941</phone>
    <email>klaferriere@t1dexchange.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>T1D Exchange</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Leon</last_name>
      <phone>617-892-0429</phone>
      <email>cleon@t1dexchange.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2020</study_first_posted>
  <last_update_submitted>November 9, 2020</last_update_submitted>
  <last_update_submitted_qc>November 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>T1D Exchange, United States</investigator_affiliation>
    <investigator_full_name>Kelsie LaFerriere</investigator_full_name>
    <investigator_title>Lead Research Study Coordinator</investigator_title>
  </responsible_party>
  <keyword>insulin</keyword>
  <keyword>t1d</keyword>
  <keyword>dm</keyword>
  <keyword>diabetes</keyword>
  <keyword>type 1</keyword>
  <keyword>glucagon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The information collected in the study may be used in future studies without additional permission from you. This may include research done by other researchers. The information that may be shared will not contain any information that could identify you. There may still be a chance that someone could identify you, but this is not likely. The study results will also be made public. These results will not have any information that could identify you.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

